CT Diagnoses in Crohn"s Disease Activity
Applications of CT in Differentiating Crohn's Disease Activity
1 other identifier
observational
35
0 countries
N/A
Brief Summary
The study focused on the clinical value of CT in assessing the activity of Crohn's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2011
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2017
CompletedFirst Submitted
Initial submission to the registry
June 29, 2021
CompletedFirst Posted
Study publicly available on registry
July 9, 2021
CompletedJuly 9, 2021
June 1, 2021
6.6 years
June 29, 2021
July 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Crohn's disease activity index (CDAI) scores
Crohn's disease activity index (CDAI) scores
1year
Study Arms (2)
CDAI≤220
According to the Crohn's disease activity index (CDAI) scores, all the patients included in the study were divided into group A (CDAI≤220)
CDAI>220
According to the Crohn's disease activity index (CDAI) scores, all the patients included in the study were divided into group B (CDAI\>220)
Eligibility Criteria
Crohn"s disease with complete CT and clinical data
You may qualify if:
- Crohn's disease patients with confirmed endoscopic or pathological examination results
- Complete laboratory data such as CRP, erythrocyte sedimentation rate, etc.
You may not qualify if:
- Related inspection results are not complete
- The interval between endoscopic and laboratory examination results exceeds 2 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jianyu Liu
Peking University Third Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2021
First Posted
July 9, 2021
Study Start
June 1, 2011
Primary Completion
December 30, 2017
Study Completion
December 30, 2017
Last Updated
July 9, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share